Robert Hilt, MD

Robert Hilt, MD is a Professor in the UW Department of Psychiatry and Behavioral Sciences and a psychiatrist at Seattle Children’s Hospital. He is the program director for the Partnership Access Line (PAL), a child mental health consultation service for primary care providers in Washington, Wyoming and Alaska. He is the Program Director for the Medicaid Medication Second Opinion Programs of Wyoming, Washington and Alaska, and Multidisciplinary Team (MDT) Psychiatric Consult Service in Wyoming for children in foster care. He has been involved in several collaborative care projects, in school support projects, and has helped to establish a statewide mental health referral service in Washington.  Dr. Hilt’s primary interest is to increase professional collaboration between child psychiatrists and pediatric medical providers, and to increase access to high quality care.

Education

Medical school: University of Rochester School of Medicine and Dentistry, Rochester
Residency: Pediatrics, University of Iowa Hospitals and Clinics, Iowa City
Residency: Psychiatry, University of Massachusetts Medical Center, Worcester
Fellowship: Child Psychiatry, University of Massachusetts Medical Center, Worcester

Department Affiliations

Other Affiliations

Partnership Access Line – Seattle Children’s Hospital
Training Clinic

Recent Publications

Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer and Targeted Use of Antipsychotics (SUAY) Clinical Trial.
(2021 May 4)
J Am Acad Child Adolesc Psychiatry
Penfold RB, Thompson EE, Hilt RJ, Schwartz N, Robb AS, Correll CU, Newton D, Rogalski K, Earls MF, Kowatch RA, Beck A, Yarborough BJH, Crystal S, Vitiello B, Kelleher KJ, Simon GE

Barriers to Increasing Access to Brief Pediatric Mental Health Treatment From Primary Care.
(2021 Jun 15)
Psychiatr Serv
Schoenfelder Gonzalez E, Jungbluth N, McCarty CA, Hilt R

Effect of Collaborative Care on Persistent Postconcussive Symptoms in Adolescents: A Randomized Clinical Trial.
(2021 Feb 1)
JAMA Netw Open 4(2): e210207
McCarty CA, Zatzick DF, Marcynyszyn LA, Wang J, Hilt R, Jinguji T, Quitiquit C, Chrisman SPD, Rivara FP

Polypharmacy in the Management of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Review and Update.
(2021 Apr)
J Child Adolesc Psychopharmacol 31(3): 148-163
Baker M, Huefner JC, Bellonci C, Hilt R, Carlson GA

Editorial: Best Practices in Child Antipsychotic Use Monitoring.
(2021 Jan)
J Am Acad Child Adolesc Psychiatry 60(1): 24-25
Hilt RJ

Show complete publication list »
Edit Profile